Last Updated: July 16, 2026

ZOHYDRO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zohydro patents expire, and what generic alternatives are available?

Zohydro is a drug marketed by Recro Gainesville and is included in one NDA. There are sixteen patents protecting this drug.

The generic ingredient in ZOHYDRO is hydrocodone bitartrate. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zohydro

A generic version of ZOHYDRO was approved as hydrocodone bitartrate by ALVOGEN on January 21st, 2020.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ZOHYDRO?
  • What are the global sales for ZOHYDRO?
  • What is Average Wholesale Price for ZOHYDRO?
Summary for ZOHYDRO
US Patents:0
Applicants:1
NDAs:1
Drug Prices: Drug price information for ZOHYDRO
Drug Sales Revenues: Drug sales revenues for ZOHYDRO
What excipients (inactive ingredients) are in ZOHYDRO?ZOHYDRO excipients list
DailyMed Link:ZOHYDRO at DailyMed

US Patents and Regulatory Information for ZOHYDRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recro Gainesville ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880-005 Oct 25, 2013 DISCN Yes No 9,610,286 ⤷  Start Trial ⤷  Start Trial
Recro Gainesville ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880-003 Oct 25, 2013 DISCN Yes No 9,713,611 ⤷  Start Trial Y ⤷  Start Trial
Recro Gainesville ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880-002 Oct 25, 2013 DISCN Yes No 10,322,120 ⤷  Start Trial Y ⤷  Start Trial
Recro Gainesville ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880-006 Oct 25, 2013 DISCN Yes No 10,092,559 ⤷  Start Trial ⤷  Start Trial
Recro Gainesville ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880-004 Oct 25, 2013 DISCN Yes No 9,326,982 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.